Case Study: Merck & Co. improves plant-to-patient supply chain reliability with TransVoyant

MSD Digital Transformation of the "Plant-to-Patient" Supply Chain

Merck & Co. partnered with TransVoyant to address the complexity of its global plant-to-patient supply chain, where temperature-controlled shipments, multiple handoffs, and frequent disruptions made it difficult to maintain product integrity and on-time delivery. The company needed better visibility, traceability, and data integration across a disparate ecosystem of partners, systems, and IoT devices.

TransVoyant implemented a digital logistics control tower, care team services, and a single source of truth for supply chain data, combining ERP, trading partner, and IoT inputs with live monitoring, alerts, lane risk assessment, and predictive insights. The result has been improved proactive intervention and continuous improvement, including prevention of more than 2.2 million doses from being discarded and avoidance of over one million vaccine doses on international shipments.

Merck & Co.

Paul Cocuzzo

Executive Director - Supply Chain and External Manufacturing IT